A Dietary Supplement Containing Cinnamon, Chromium and Carnosine Decreases Fasting Plasma Glucose and Increases Lean Mass in Overweight or Obese Pre-Diabetic Subjects: A Randomized, Placebo-Controlled Trial
Open accessThe DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Preventing or slowing the progression of prediabetes to diabetes is a major therapeutic issue. OBJECTIVES: Our aim was to evaluate the effects of 4-month treatment with a dietary supplement containing cinnamon, chromium and carnosine in moderately obese or overweight pre-diabetic subjects, the primary outcome being change in fasting plasma glucose (FPG) level. Other parameters of plasma glucose homeostasis, lipid profile, adiposity and inflammatory markers were also assessed. METHODS: In a randomized, double-blind, placebo-controlled study, 62 subjects with a FPG level ranging from 5.55 to 7 mmol/L and a body mass index ≥ 25 kg/m(2), unwilling to change their dietary and physical activity habits, were allocated to receive a 4-month treatment with either 1.2 g/day of the dietary supplement or placebo. Patients were followed up until 6 months post-randomization. RESULTS: Four-month treatment with the dietary supplement decreased FPG compared to placebo (-0.24 ± 0.50 vs +0.12 ± 0.59 mmol/L, respectively, p = 0.02), without detectable significant changes in HbA1c. Insulin sensitivity markers, plasma insulin, plasma lipids and inflammatory markers did not differ between the treatment groups. Although there were no significant differences in changes in body weight and energy or macronutrient intakes between the two groups, fat-free mass (%) increased with the dietary supplement compared to placebo (p = 0.02). Subjects with a higher FPG level and a milder inflammatory state at baseline benefited most from the dietary supplement. CONCLUSIONS: Four-month treatment with a dietary supplement containing cinnamon, chromium and carnosine decreased FPG and increased fat-free mass in overweight or obese pre-diabetic subjects. These beneficial effects might open up new avenues in the prevention of diabetes. TRIAL REGISTRATION: ClinicalTrials.gov NCT01530685.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A systematic review on the effect of chromium supplementation on glucose and lipid metabolism concluded that evidence is limited by poor study quality and heterogeneity in methodology and results (239,240).”
From Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report (2019) · cites this paper as [240]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
nlme : Linear and nonlinear mixed effects models
DebRoy, S. (2006) · Medical Entomology and Zoology · Cited by 10,009
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059 · cited 1×
“However, in pre-diabetic patients as in the present study, the modest decrease in FPG will prevent the development of diabetes with its associated micro- and macrovascular complications [58;59].”
BackgroundStandards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Haffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
nlme: Linear and Nonlinear Mixed Effects Models
Pinheiro, J., R Core Team, & Bates, D. (1999) · CRAN: Contributed Packages · doi:10.32614/cran.package.nlme · Cited by 6,849
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s062 · Cited by 5,491
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger
Stunkard, A. J., & Messick, S. (1985) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(85)90010-8 · Cited by 4,687 · cited 1×
“Lifestyle was evaluated using the Three-Factor Eating Questionnaire [33] and Baecke physical activity questionnaire [34].”
MethodStandards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Pan, X.-R., Li, G.-W., Hu, Y.-H., Wang, J.-X., Yang, W.-Y., An, Z.-X., Hu, Z.-X., Juan-Lin, Xiao, J.-Z., Cao, H.-B., et al. (1997) · Diabetes Care · doi:10.2337/diacare.20.4.537 · Cited by 4,320
A short questionnaire for the measurement of habitual physical activity in epidemiological studies
Baecke, J., Burema, J., & Frijters, J. (1982) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/36.5.936 · Cited by 3,945 · cited 1×
“Lifestyle was evaluated using the Three-Factor Eating Questionnaire [33] and Baecke physical activity questionnaire [34].”
MethodDiagnosis and Classification of diabetes mellitus
(2014) · Diapedia · doi:10.14496/dia..20 · Cited by 3,214
Prediabetes: a high-risk state for diabetes development
Tabák, A. G., Herder, C., Rathmann, W., Brunner, E. J., & Kivimäki, M. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60283-9 · Cited by 2,958 · cited 3×
“Moreover, micro- and macrovascular damage is already present in pre-diabetic individuals [5–9].”
BackgroundAcarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543 · cited 1×
“Interestingly, 23% of subjects in our dietary supplement group showed continued improvement in FPG level after treatment cessation, a percentage approaching consistency with the 35% to 50% rate of regression to normal glucose tolerance observed in some large intervention trials [55;56;62].”
Result(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Li, G., Zhang, P., Wang, J., Gregg, E. W., Yang, W., Gong, Q., Li, H., Li, H., Jiang, Y., An, Y., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60766-7 · Cited by 1,600
Nutrition therapy recommendations for the management of adults with diabetes
Evert, A. B., Boucher, J. L., Cypress, M., Dunbar, S. A., Franz, M. J., Mayer-Davis, E. J., Neumiller, J. J., Nwankwo, R., Verdi, C. L., Urbanski, P., et al. (2013) · Diabetes Care · doi:10.2337/dc13-2042 · Cited by 1,129 · cited 1×
“In view of the conflicting results of available clinical studies evaluating cinnamon [17–20] and chromium [23;37–39], the American Diabetes Association currently considers that there is insufficient evidence to support their use in subjects with diabetes [3;40].”
ResultCinnamon improves glucose and lipids of people with type 2 diabetes
Khan, A., Safdar, M., Ali Khan, M. M., Khattak, K. N., & Anderson, R. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3215 · Cited by 981 · cited 1×
“However, despite promising initial findings in T2D patients [15], subsequent clinical studies have generated conflicting results, probably owing to differences in the population included, dose range, dosage form, treatment duration, confounding concomitant treatments and quality of study design [16–20].”
ResultEuropean Food Safety Authority (EFSA)
Ramos-Peralonso, M. J. (2014) · Encyclopedia of Toxicology · doi:10.1016/b978-0-12-386454-3.00563-7 · Cited by 916
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Henry, R. R., Hodis, H. N., Kitabchi, A. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010949 · Cited by 766 · cited 1×
“Interestingly, 23% of subjects in our dietary supplement group showed continued improvement in FPG level after treatment cessation, a percentage approaching consistency with the 35% to 50% rate of regression to normal glucose tolerance observed in some large intervention trials [55;56;62].”
ResultNutrition therapy recommendations for the management of adults with diabetes
Evert, A. B., Boucher, J. L., Cypress, M., Dunbar, S. A., Franz, M. J., Mayer-Davis, E. J., Neumiller, J. J., Nwankwo, R., Verdi, C. L., Urbanski, P., et al. (2014) · Diabetes Care · doi:10.2337/dc14-s120 · Cited by 766
(2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.10.013 · Cited by 609
Srikanthan, P., Hevener, A. L., & Karlamangla, A. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010805 · Cited by 600
Anderson, R. A., Broadhurst, C. L., Polansky, M. M., Schmidt, W. F., Khan, A., Flanagan, V. P., Schoene, N. W., & Graves, D. J. (2004) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf034916b · Cited by 561 · cited 1×
“The dietary supplement contained a cinnamon bark (Cinnamomum cassia) extract rich in polyphenol type-A polymers currently considered to be the bioactive components of cinnamon [41].”
BackgroundMedicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): a systematic review
Ranasinghe, P., Pigera, S., Premakumara, G. S., Galappaththy, P., Constantine, G. R., & Katulanda, P. (2013) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-13-275 · Cited by 483 · cited 1×
“However, data on the efficacy of Cinnamomum zeylanicum in humans are sparse [45] and no randomized double-blinded placebo-controlled clinical trials are available to establish the therapeutic efficacy and safety of Cinnamomum zeylanicum as a pharmaceutical agent.”
BackgroundA European Evidence-Based Guideline for the Prevention of Type 2 Diabetes
Paulweber, B., Valensi, P., Lindström, J., Lalic, N., Greaves, C., McKee, M., Kissimova-Skarbek, K., Liatis, S., Cosson, E., Szendroedi, J., et al. (2010) · Hormone and Metabolic Research · doi:10.1055/s-0029-1240928 · Cited by 469
Effects of a cinnamon extract on plasma glucose, HbA1c, and serum lipids in diabetes mellitus type 2
Mang, B., Wolters, M., Schmitt, B., Kelb, K., Lichtinghagen, R., Stichtenoth, D. O., & Hahn, A. (2006) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2006.01629.x · Cited by 354 · cited 1×
“HbA1c contrary to its effect on FPG [48].”
BackgroundQin, B., Nagasaki, M., Ren, M., Bajotto, G., Oshida, Y., & Sato, Y. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00173-6 · Cited by 298 · cited 1×
“Among these, cinnamon has been shown to possess anti-diabetic and anti-inflammatory properties in experimental studies [11–14].”
BackgroundEffect of Chromium Supplementation on Glucose Metabolism and Lipids
Balk, E. M., Tatsioni, A., Lichtenstein, A. H., Lau, J., & Pittas, A. G. (2007) · Diabetes Care · doi:10.2337/dc06-0996 · Cited by 294
Martins, A. R., Nachbar, R. T., Gorjao, R., Vinolo, M. A., Festuccia, W. T., Lambertucci, R. H., Cury-Boaventura, M. F., Silveira, L. R., Curi, R., & Hirabara, S. M. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-30 · Cited by 290 · cited 1×
“Several evidences support the involvement of free fatty acids in the development of skeletal muscle insulin resistance [68].”
BackgroundGarber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., Davidson, M. B., Einhorn, D., Timothy Garvey, W., et al. (2013) · Endocrine Practice · doi:10.4158/ep13176.cs · Cited by 280 · cited 2×
“Moreover, micro- and macrovascular damage is already present in pre-diabetic individuals [5–9].”
BackgroundInsulin resistance, inflammation, and the prediabetic state
Haffner, S. M. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00612-x · Cited by 274 · cited 1×
“Chronic inflammation appears to be a central mediator of insulin resistance associated with obesity [69] or pre-diabetes [70–72].”
BackgroundCinnamon use in type 2 diabetes: an updated systematic review and meta-analysis
Allen, R. W., Schwartzman, E., Baker, W. L., Coleman, C. I., & Phung, O. J. (2013) · The Annals of Family Medicine · doi:10.1370/afm.1517 · Cited by 269 · cited 1×
“This is in agreement with a previous study in pre-diabetic subjects (21) and with a recent meta-analysis [19] in T2D patients.”
ResultInverse associations between muscle mass, strength, and the metabolic syndrome
Atlantis, E., Martin, S. A., Haren, M. T., Taylor, A. W., & Wittert, G. A. (2009) · Metabolism · doi:10.1016/j.metabol.2009.02.027 · Cited by 258
Crawford, P. (2009) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2009.05.080093 · Cited by 246 · cited 1×
“In the meta-analysis, the only two trials showing beneficial effect of cinnamon on HbA1c included diabetic patients with HbA1c levels greater than 8% [46;47].”
BackgroundGarber, A. J., Handelsman, Y., Einhorn, D., Bergman, D. A., Bloomgarden, Z. T., Fonseca, V., Garvey, W. T., Gavin, J. R., Grunberger, G., Horton, E. S., et al. (2008) · Endocrine Practice · doi:10.4158/ep.14.7.933 · Cited by 237 · cited 2×
“Moreover, micro- and macrovascular damage is already present in pre-diabetic individuals [5–9].”
BackgroundFesta, A., Hanley, A. J. G., Tracy, R. P., D’Agostino, R., & Haffner, S. M. (2003) · Circulation · doi:10.1161/01.cir.0000091339.70120.53 · Cited by 232 · cited 1×
“Chronic inflammation appears to be a central mediator of insulin resistance associated with obesity [69] or pre-diabetes [70–72].”
BackgroundAkilen, R., Tsiami, A., Devendra, D., & Robinson, N. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03079.x · Cited by 230 · cited 1×
“In the meta-analysis, the only two trials showing beneficial effect of cinnamon on HbA1c included diabetic patients with HbA1c levels greater than 8% [46;47].”
BackgroundZiegenfuss, T. N., Hofheins, J. E., Mendel, R. W., Landis, J., & Anderson, R. A. (2006) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-3-2-45 · Cited by 227 · cited 7×
“As in the previous study investigating the benefits of cinnamon in pre-diabetic subjects [21], we did not find any difference between the dietary supplement and placebo groups with respect to lipid homeostasis.”
BackgroundMethodResultInfluentialRoussel, A.-M., Hininger, I., Benaraba, R., Ziegenfuss, T. N., & Anderson, R. A. (2009) · Journal of the American College of Nutrition · doi:10.1080/07315724.2009.10719756 · Cited by 210 · cited 14×
“Although, in diabetic patients, traditionally available therapeutic options reduce blood glucose concentrations, and subsequently improve pancreatic beta-cell function, none of the available anti-hyperglycemic agents changes the natural progression of T2D [57].”
BackgroundInfluentialMartin, J., Wang, Z. Q., Zhang, X. H., Wachtel, D., Volaufova, J., Matthews, D. E., & Cefalu, W. T. (2006) · Diabetes Care · doi:10.2337/dc06-0254 · Cited by 207
Sheng, X., Zhang, Y., Gong, Z., Huang, C., & Zang, Y. Q. (2008) · PPAR Research · doi:10.1155/2008/581348 · Cited by 203 · cited 1×
“Among these, cinnamon has been shown to possess anti-diabetic and anti-inflammatory properties in experimental studies [11–14].”
BackgroundThe Cardiometabolic Syndrome and Sarcopenic Obesity in Older Persons
Dominguez, L. J., & Barbagallo, M. (2007) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4564.2007.06673.x · Cited by 185 · cited 1×
“Since muscle constitutes the largest portion of insulin-sensitive tissue in the body, decrease in fat-free mass may be an important factor with regard to insulin resistance and risk of T2D [65–67].”
BackgroundRanasinghe, P., Jayawardana, R., Galappaththy, P., Constantine, G. R., de Vas Gunawardana, N., & Katulanda, P. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03718.x · Cited by 176
Miller, C. T., Fraser, S. F., Levinger, I., Straznicky, N. E., Dixon, J. B., Reynolds, J., & Selig, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081692 · Cited by 160 · cited 1×
“We believe this finding is important considering the role of lean mass in the long-term maintenance of metabolic rate, core body temperature, skeletal integrity, muscle strength, functional capacities, and prevention of sarcopenic obesity [64].”
BackgroundSuksomboon, N., Poolsup, N., & Yuwanakorn, A. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12147 · Cited by 154 · cited 2×
“Two recent meta-analyses assessing the interest of chromium supplementation in the context of diabetes led to contradictory conclusions: The first one [38], based on 16 clinical studies, failed to show any benefit, whereas the second one [73] that included 22 studies concluded favorable effects of chromium supplementa…”
BackgroundResultVafa, M., Mohammadi, F., Shidfar, F., Sormaghi, M. H. S., Heidari, I., Golestan, B., & Amiri, F. (2012) · PubMed Central · Cited by 153
Cinnamon extract prevents the insulin resistance induced by a high-fructose diet
(2004) · Hormone and Metabolic Research · doi:10.1055/s-2004-814223 · Cited by 152 · cited 1×
“Among these, cinnamon has been shown to possess anti-diabetic and anti-inflammatory properties in experimental studies [11–14].”
BackgroundEffects of Chromium on Body Composition and Weight Loss
Anderson, R. A. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1998.tb01763.x · Cited by 131 · cited 2×
“Finally, both cinnamon and chromium have been suggested to have favorable effects on body composition [21;27].”
BackgroundChromium picolinate for reducing body weight: Meta-analysis of randomized trials
Pittler, M. H., Stevinson, C., & Ernst, E. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802262 · Cited by 131 · cited 1×
“Meta-analyses of trials in overweight or obese patients showed that chromium was associated with statistically significant reductions in body weight and percentage body fat, although these effects were considered to be of small magnitude and uncertain clinical relevance [24;37].”
BackgroundCarnosine: A Versatile Antioxidant and Antiglycating Agent
Reddy, V. P., Garrett, M. R., Perry, G., & Smith, M. A. (2005) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2005.18.pe12 · Cited by 129 · cited 2×
“Another micronutrient candidate that could also be considered in this context is carnosine, a naturally occurring compound with antiglycation and antiaging activities [26], which might potentiate any favorable effect of cinnamon on glycemic control in pre-diabetic subjects.”
BackgroundCinnamon in glycaemic control: Systematic review and meta analysis
Akilen, R., Tsiami, A., Devendra, D., & Robinson, N. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.04.003 · Cited by 124 · cited 2×
“However, despite promising initial findings in T2D patients [15], subsequent clinical studies have generated conflicting results, probably owing to differences in the population included, dose range, dosage form, treatment duration, confounding concomitant treatments and quality of study design [16–20].”
ResultCinnamon Intake Lowers Fasting Blood Glucose: Meta-Analysis
Davis, P. A., & Yokoyama, W. (2011) · Journal of Medicinal Food · doi:10.1089/jmf.2010.0180 · Cited by 121 · cited 3×
“Finally, the 4-month duration of treatment in the present study is one of the longest evaluated to date for cinnamon [17– 20] and constitutes the recommended minimal duration in trials assessing the benefits of chromium [37].”
BackgroundResultCinnamon for diabetes mellitus
Leach, M. J., & Kumar, S. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007170.pub2 · Cited by 118
Possible Role of L-Carnosine in the Regulation of Blood Glucose through Controlling Autonomic Nerves
Nagai, K., Niijima, A., Yamano, T., Otani, H., Okumra, N., Tsuruoka, N., Nakai, M., & Kiso, Y. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322801007 · Cited by 108 · cited 1×
“In experimental studies, carnosine limited oxidative stress and inflammation, prevented protein cross-linking both in diabetic animals and in otherwise healthy aging animals, and appeared to possibly play a role in the regulation of blood glucose level via an effect on the autonomic nervous system [26;77;78].”
BackgroundRanasinghe, P. D., Gunatilake, M., Gunapala, N., Perera, P. K., Katulanda, P., Perera, S., Abeywardene, E., Premakumara, G. A. S., & Lokuhetty, D. (2012) · Pharmacognosy Research · doi:10.4103/0974-8490.94719 · Cited by 106 · cited 1×
“Concerning the type of cinnamon, Cinnamomum zeylanicum, however, is regarded to be more effective and safe than Cinnamomum cassia which is characterized by high concentrations of coumarins that may cause health risks [42;43].”
BackgroundManagement of hyperglycaemia in type 2 diabetes: the end of recurrent failure?
Heine, R. J., Diamant, M., Mbanya, J.-C., & Nathan, D. M. (2006) · BMJ · doi:10.1136/bmj.39022.462546.80 · Cited by 100 · cited 14×
“Although, in diabetic patients, traditionally available therapeutic options reduce blood glucose concentrations, and subsequently improve pancreatic beta-cell function, none of the available anti-hyperglycemic agents changes the natural progression of T2D [57].”
BackgroundInfluentialCrawford, V., Scheckenbach, R., & Preuss, H. G. (1999) · Diabetes, Obesity and Metabolism · doi:10.1046/j.1463-1326.1999.00055.x · Cited by 96 · cited 1×
“Importantly, several clinical studies showed that chromium supplementation increased lean body mass and decreased fat body mass in overweight or obese subjects [27;75;76].”
BackgroundOnakpoya, I., Posadzki, P., & Ernst, E. (2013) · Obesity Reviews · doi:10.1111/obr.12026 · Cited by 93 · cited 2×
“Finally, the 4-month duration of treatment in the present study is one of the longest evaluated to date for cinnamon [17– 20] and constitutes the recommended minimal duration in trials assessing the benefits of chromium [37].”
BackgroundHsueh, W., McLellan, K., Wyne, K., & Villagomez, E. (2014) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s39564 · Cited by 91 · cited 4×
“Moreover, micro- and macrovascular damage is already present in pre-diabetic individuals [5–9].”
BackgroundInfluentialNagai, K., Tanida, M., Niijima, A., Tsuruoka, N., Kiso, Y., Horii, Y., Shen, J., & Okumura, N. (2012) · Amino Acids · doi:10.1007/s00726-012-1251-9 · Cited by 84 · cited 1×
“In experimental studies, carnosine limited oxidative stress and inflammation, prevented protein cross-linking both in diabetic animals and in otherwise healthy aging animals, and appeared to possibly play a role in the regulation of blood glucose level via an effect on the autonomic nervous system [26;77;78].”
BackgroundControversies surrounding the clinical potential of cinnamon for the management of diabetes
Rafehi, H., Ververis, K., & Karagiannis, T. C. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01538.x · Cited by 80 · cited 1×
“In our study, no difference was seen between the treatment groups in terms of inflammatory markers, an unexpected finding considering the anti-inflammatory effect of cinnamon observed in experimental studies [16].”
ResultPellegrinelli, V., Rouault, C., Veyrie, N., Clément, K., & Lacasa, D. (2014) · Diabetes · doi:10.2337/db13-0537 · Cited by 77 · cited 1×
“medium then being collected and frozen at -80°C for determination of IL-6 and adiponectin levels [29].”
BackgroundSelf-citationRizkalla, S. W., Prifti, E., Cotillard, A., Pelloux, V., Rouault, C., Allouche, R., Laromiguière, M., Kong, L., Darakhshan, F., Massiéra, F., et al. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.017277 · Cited by 76 · cited 1×
“For adipocyte diameter measurement, a portion of each SCAT biopsy sample was immediately isolated by collagenase digestion and cell size measurements were performed as previously described [28].”
MethodSelf-citationAbdollahi, M., Farshchi, A., Nikfar, S., & Seyedifar, M. (2013) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3g022 · Cited by 67 · cited 1×
“The use of chromium in the treatment of T2D has been debated [39;73;74].”
BackgroundIncani, M., Sentinelli, F., Perra, L., Pani, M. G., Porcu, M., Lenzi, A., Cavallo, M. G., Cossu, E., Leonetti, F., & Baroni, M. G. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12241 · Cited by 66 · cited 1×
“It has been demonstrated that there is a poor agreement between FPG and low HbA1c values and that normal range HbA1c is less sensitive to variations in FPG [49].”
BackgroundBragg, F., Li, L., Smith, M. C., Guo, Y., Chen, Y., Millwood, I. Y., Bian, Z., Walters, R. G., Chen, J., Yang, L., et al. (2013) · Diabetic Medicine · doi:10.1111/dme.12392 · Cited by 66 · cited 1×
“Moreover, epidemiological evidence shows that cardiovascular diseases might start at low plasma glucose levels, below the level defined for diabetes and even for impaired glucose tolerance [60;61].”
BackgroundMedagama, A. B., Bandara, R., Abeysekera, R. A., Imbulpitiya, B., & Pushpakumari, T. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-374 · Cited by 60 · cited 1×
“It has been suggested that the effect of cinnamon is minimal when glucose control is closer to normal and that it exerts a significant effect in reducing FPG as the values slightly increase [50].”
BackgroundImproved Meta-Analytic Methods Show No Effect of Chromium Supplements on Fasting Glucose
Bailey, C. H. (2013) · Biological Trace Element Research · doi:10.1007/s12011-013-9863-9 · Cited by 54 · cited 1×
“Two recent meta-analyses assessing the interest of chromium supplementation in the context of diabetes led to contradictory conclusions: The first one [38], based on 16 clinical studies, failed to show any benefit, whereas the second one [73] that included 22 studies concluded favorable effects of chromium supplementa…”
ResultSeyal, M. S. (2010) · JAMA · doi:10.1001/jama.2010.1130 · Cited by 54
Inflammation, Insulin Resistance, and Atherosclerosis
Theuma, P., & Fonseca, V. A. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/1540419042441876 · Cited by 43 · cited 1×
“Chronic inflammation appears to be a central mediator of insulin resistance associated with obesity [69] or pre-diabetes [70–72].”
Background(EFSA), E. F. S. A. (2008) · EFSA Journal · doi:10.2903/j.efsa.2008.729 · Cited by 41
Qin, B., Dawson, H., Polansky, M. M., & Anderson, R. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0029-1202813 · Cited by 40 · cited 1×
“Among these, cinnamon has been shown to possess anti-diabetic and anti-inflammatory properties in experimental studies [11–14].”
BackgroundKleefstra, N., Houweling, S. T., & Bilo, H. J. G. (2007) · Diabetes Care · doi:10.2337/dc07-1015 · Cited by 37
Prediabetes: To treat or not to treat?
Moutzouri, E., Tsimihodimos, V., Rizos, E. C., & Elisaf, M. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.10.007 · Cited by 36 · cited 4×
“Moreover, micro- and macrovascular damage is already present in pre-diabetic individuals [5–9].”
BackgroundInfluentialInsulin Stimulates Nitric Oxide Production in Rat Adipocytes
Ribière, C., Jaubert, A., Sabourault, D., Lacasa, D., & Giudicelli, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6444 · Cited by 34 · cited 2×
“Metabolic activity of adipose tissue in vitro (secretion of adiponectin and IL-6, insulin sensitivity estimated by the measurement of serine/threonine protein kinase B [PKB, also known as Akt]) was also explored, and dietary intakes and lifestyle were assessed.”
BackgroundAntuna-Puente, B., Disse, E., Faraj, M., Lavoie, M.-È., Laville, M., RABASA-LHORET, R. P. R., & Bastard, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0091 · Cited by 30 · cited 1×
“We used several surrogates to estimate pancreatic β cell function (insulin secretion) and insulin sensitivity using the Homeostasis Model Assessment—Continuous Infusion Glucose Model Assessment (HOMA-CIGMA) [31] and Disse indices [32].”
MethodSelf-citationKim, C., Kim, B.-T., Park, K., Kim, K., Lee, D.-J., Yang, S.-W., & Joo, N. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.10.001 · Cited by 21
Lü, Q., Tong, N., Liu, Y., Li, N., Tang, X., Zhao, J., Cao, H., Li, D., Gou, L., Zhang, Y., et al. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.03.002 · Cited by 21 · cited 1×
“Chronic inflammation appears to be a central mediator of insulin resistance associated with obesity [69] or pre-diabetes [70–72].”
BackgroundSelf-citationDysglycemia and the Risk of Cardiovascular Events
Gerstein, H. C., & Punthakee, Z. (2009) · Wiley eBooks · doi:10.1002/9781444309768.ch14 · Cited by 4
Research works printed but not linked: 1
- Lemon J. Plotrix: a package in the red light district of R. R-News. 2006; 6(4): 8– 12.
Cited by
Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report
Evert, A. B., Dennison, M., Gardner, C. D., Garvey, W. T., Lau, K. H. K., MacLeod, J., Mitri, J., Pereira, R. F., Rawlings, K., Robinson, S., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0014 · Cited by 1,496
Histidine in Health and Disease: Metabolism, Physiological Importance, and Use as a Supplement
Holeček, M. (2020) · Nutrients · doi:10.3390/nu12030848 · Cited by 485
Wu, G. (2020) · Amino Acids · doi:10.1007/s00726-020-02823-6 · Cited by 475
Papakonstantinou, E., Oikonomou, C., Nychas, G., & Dimitriadis, G. D. (2022) · Nutrients · doi:10.3390/nu14040823 · Cited by 199
Brannick, B., Wynn, A., & Dagogo-Jack, S. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216654227 · Cited by 177
“Besides pharmaceutical agents, nutraceuticals have been proposed as an alternative remedy for mitigating diabetes risk; however, there is insufficient evidence to support that approach.(75) Indeed, the desirable characteristics of an acceptable drug for the primary prevention of T2DM set a high bar that has so far bee…”
Background
Metadata
- Authors
- Liu, Y., Cotillard, A., Vatier, C., Bastard, J.-P., Fellahi, S., Stévant, M., Allatif, O., Langlois, C., Bieuvelet, S., Brochot, A., Guilbot, A., Clément, K., & Rizkalla, S. W.
- Affiliations
- Inserm (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- PiLeJe (France) (FR)
- Corresponding author
- Rizkalla, Salwa W.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-09-25
- Volume
- 10
- Issue
- 9
- Pages
- e0138646
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4583280
- OpenAlex
- W2193486063
- Cited by
- 71
- References
- 86
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 7 · 2021: 11 · 2020: 12 · 2019: 12 · 2018: 8 · 2017: 6 · 2016: 3 · 2015: 1
- FWCI
- 5.22
- Type
- journal article
- Language
- en
- Update notices
- correction (2015-12-14)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Université Pierre et Marie Curie
- Assistance publique-Hôpitaux de Paris
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- cinnamon, chromium, carnosine, dietary supplements, prediabetes, fasting blood glucose, fat-free mass, obesity, overweight, diabetes prevention, insulin sensitivity, inflammatory markers, lipid profile
- MeSH terms
- Adult, Aged, Blood Glucose, Body Composition, Carnosine, Chromium, Cinnamomum zeylanicum, Diabetes Mellitus, Type 2, Double-Blind Method, Fasting, Female, Humans, Male, Middle Aged, Muscles, Obesity, Placebos, Plant Extracts, Prediabetic State, Dietary Supplements, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.